Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Willing Bio-Tech is a specialized biotechnology company based in China that focuses on the research, development, and commercialization of veterinary biological products. The company is a significant player in the animal health industry, providing a wide range of vaccines and diagnostic reagents for swine, poultry, and other livestock. Operating out of Changzhou, Jiangsu, it utilizes state-of-the-art GMP-certified facilities to produce high-quality biologics aimed at controlling major animal epidemics. Their portfolio includes advanced solutions for Classical Swine Fever and Avian Influenza, supported by strong technical service and R&D capabilities. By integrating research, production, and technical services, Jiangsu Willing Bio-Tech supports the biosecurity and productivity of the global agricultural industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Willing Bio-Tech.